shutterstock_2091347611_ralf_liebhold
Ralf Liebhold / Shutterstock.com
15 February 2022GenericsAlex Baldwin

Afrigen creates COVID vaccine using Moderna data

Afrigen Biologics has used the publicly available information relating to Moderna’s COVID-19 vaccine to manufacture its own version of the treatment, which could see testing by the end of this year.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
11 November 2021   Moderna is facing accusations from the US National Institute of Health that it failed to give due recognition to three scientists as inventors on its COVID-19 vaccine application.
Big Pharma
8 March 2022   Moderna has stated that it will “never” enforce its COVID-19 patents in 92 low and middle-income countries.
Americas
10 May 2022   Moderna has rejected claims that its COVID-19 vaccine violates the patent rights of two biopharma companies, arguing that its contract with the US federal government has conferred immunity.

More on this story

Americas
11 November 2021   Moderna is facing accusations from the US National Institute of Health that it failed to give due recognition to three scientists as inventors on its COVID-19 vaccine application.
Big Pharma
8 March 2022   Moderna has stated that it will “never” enforce its COVID-19 patents in 92 low and middle-income countries.
Americas
10 May 2022   Moderna has rejected claims that its COVID-19 vaccine violates the patent rights of two biopharma companies, arguing that its contract with the US federal government has conferred immunity.

More on this story

Americas
11 November 2021   Moderna is facing accusations from the US National Institute of Health that it failed to give due recognition to three scientists as inventors on its COVID-19 vaccine application.
Big Pharma
8 March 2022   Moderna has stated that it will “never” enforce its COVID-19 patents in 92 low and middle-income countries.
Americas
10 May 2022   Moderna has rejected claims that its COVID-19 vaccine violates the patent rights of two biopharma companies, arguing that its contract with the US federal government has conferred immunity.